March 2025 Networking Event Recap: Unlocking Success in Biotech
Event Date: March 19, 2025
This biotech networking event recap highlights key insights from the GLSA March 2025 session focused on funding, leadership, and collaboration across the life sciences industry. On March 19, the Global Life Sciences Alliance (GLSA) hosted a virtual event that brought together industry leaders, entrepreneurs, and clinical research professionals to discuss emerging trends and best practices in biotech.
More importantly, the event created space for meaningful connection. Attendees exchanged ideas, shared insights, and expanded their professional networks—many continuing conversations through LinkedIn after the session.
Women in Life Sciences: Building a Stronger Community
During the event, Denise McNerney highlighted the Women of Life Sciences group and its growing role in fostering collaboration and career growth. She emphasized that community-driven networking is essential for advancing innovation and creating a more inclusive life sciences industry.
As healthcare and biotech continue to evolve, forums like these help bridge gaps between professionals and provide valuable support at every career stage.
Expanding Clinical Research Networks and Conference Opportunities
Chris Matheus shared updates on the rapid growth of the GLSA Network, which now collaborates with more than 150 vendors, service providers, consultants, and advisors. He also reflected on insights from recent industry conferences and how these events help shape strategic partnerships.
Additionally, Deb Kientop discussed upcoming conferences and potential registration opportunities, encouraging attendees to stay engaged and continue building their industry presence.
Success in Biotech: Beyond Scientific Achievements
Deb Kientop also explored what success in biotech truly looks like today. While scientific innovation remains critical, investors are increasingly focused on the strength of leadership teams and the clarity of commercialization strategies.
Key factors discussed included:
-
High-quality data and regulatory compliance
-
Strategic team-building and experienced leadership
-
Early commercial planning to attract investors
-
Efficient and realistic clinical trial budget management
Denise echoed these points, noting that strong emotional investment in scientific work—while understandable—can sometimes make objective business decision-making more challenging.
The Role of Automation and Digital Tools
As the conversation turned to funding, participants discussed the growing importance of automation and digital tools. Startups that embrace automated systems are often better positioned to streamline commercialization, improve efficiency, and expand investor outreach.
In addition, crowdfunding and digital platforms are becoming increasingly relevant. Companies that leverage these tools effectively can gain a competitive advantage in both fundraising and speed to market.
Key Takeaways for Biotech Professionals
This biotech networking event recap reinforces the importance of connection, strategy, and collaboration in today’s evolving biotech landscape.
Several clear takeaways emerged from the discussion:
-
Networking matters: Active engagement with industry groups and conferences opens doors to new opportunities
-
Investors value strong teams: Leadership, strategy, and execution matter as much as science
-
Funding requires planning: Clear communication and automation can strengthen fundraising efforts
-
Therapeutic focus counts: Areas like oncology continue to attract strong investor interest
Looking Ahead
Overall, this biotech networking event recap reflects the value of community-driven conversations in driving biotech innovation forward. The event concluded with a strong sense of optimism and collaboration. In a rapidly evolving biotech landscape, community-driven forums like GLSA’s networking sessions play a vital role in helping professionals navigate challenges, share knowledge, and drive innovation forward.
Stay Connected
GLSA hosts monthly networking events through Zoom, typically on the third Wednesday of each month at 6:00 PM ET. These sessions are an open house for professionals to connect, share insights, and collaborate.
To stay updated on future events, make sure to sign up here:
Get GLSA Event Notifications
You can also join the Women of Life Sciences LinkedIn group:
Women of Life Sciences Group Information and Event Notifications
Our Mission
The Global Life Sciences Alliance is dedicated to providing pre-clinical and clinical research solutions by connecting people and companies within the life sciences industry. With a network of over 150 pre-clinical and clinical research service providers, we are here to help solve challenges and foster collaboration. When you face a challenge or have a need, don’t hesitate to reach out! Helping you is what drives us.
We look forward to seeing you at our next event and continuing to make an impact together!
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.